Lixte Biotechnology
LIXT
LIXT
10 hedge funds and large institutions have $148K invested in Lixte Biotechnology in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
62% less capital invested
Capital invested by funds: $385K → $148K (-$237K)
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4K | |
| 2 | +$1.28K | |
| 3 | +$121 | |
| 4 |
CS
Clear Street
New York
|
+$120 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$60 |
Top Sellers
| 1 | -$129K | |
| 2 | -$29.7K | |
| 3 | -$8.62K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.81K |